We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.08T
AUM Growth
+$125B
Cap. Flow
+$32.6B
Cap. Flow %
3.01%
Top 10 Hldgs %
27.52%
Holding
4,738
New
85
Increased
3,720
Reduced
276
Closed
123

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.81B
2
MSFT icon
Microsoft
MSFT
+$1.34B
3
AAPL icon
Apple
AAPL
+$1.25B
4
AMZN icon
Amazon
AMZN
+$1.17B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$373M
2
AMGN icon
Amgen
AMGN
+$204M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$180M
4
IMGN
Immunogen Inc
IMGN
+$160M
5
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$109M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Financials 12.91%
3 Healthcare 12.22%
4 Consumer Discretionary 10.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOBX icon
3826
Mobix Labs
MOBX
$26M
$277K ﹤0.01%
+13,802
New +$352K
SLS icon
3827
SELLAS Life Sciences
SLS
$2.36B
$276K ﹤0.01%
273,063
+27,460
+11% +$23.1K
DUOT icon
3828
Duos Technologies
DUOT
$290M
$275K ﹤0.01%
63,364
-1,160
-2% -$4.47K
USIO icon
3829
Usio Inc
USIO
$64M
$275K ﹤0.01%
161,480
– –
VTRU
3830
DELISTED
Vitru Limited Common Shares
VTRU
$274K ﹤0.01%
19,023
– –
BNED icon
3831
Barnes & Noble Education
BNED
$443M
$273K ﹤0.01%
3,775
+69
+2% +$6.39K
ENGN icon
3832
enGene Therapeutics
ENGN
$121M
$273K ﹤0.01%
+16,126
New +$197K
TCRT icon
3833
Alaunos Therapeutics
TCRT
$4.86M
$272K ﹤0.01%
15,042
– –
DIT icon
3834
AMCON Distributing
DIT
$271K ﹤0.01%
2,211
– –
LABP
3835
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$271K ﹤0.01%
12,604
– –
ASRV icon
3836
AmeriServ Financial
ASRV
$83.5M
$270K ﹤0.01%
103,674
– –
MODD icon
3837
Modular Medical
MODD
$11.9M
$268K ﹤0.01%
4,835
+1,634
+51% +$87.8K
USAU icon
3838
US Gold Corp
USAU
$258M
$267K ﹤0.01%
72,726
+1,208
+2% +$4.42K
CXAI icon
3839
CXApp
CXAI
$17.5M
$267K ﹤0.01%
108,902
+61,963
+132% +$106K
NMTC icon
3840
NeuroOne Medical Technologies
NMTC
$14.2M
$266K ﹤0.01%
36,992
+4,138
+13% +$31.3K
NTRB icon
3841
Nutriband
NTRB
$37.8M
$265K ﹤0.01%
58,571
– –
CPBI icon
3842
Central Plains Bancshares
CPBI
$86.1M
$265K ﹤0.01%
25,895
+6,335
+32% +$65.5K
BINI
3843
DELISTED
Bollinger Innovations
BINI
– –
0
– –
USCT
3844
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
$263K ﹤0.01%
23,623
– –
TMC icon
3845
TMC The Metals Company
TMC
$1.98B
$263K ﹤0.01%
184,173
– –
FTLF icon
3846
FitLife Brands
FTLF
$94.2M
$263K ﹤0.01%
22,972
+2,310
+11% +$25.1K
AIRT icon
3847
Air T
AIRT
$86.1M
$262K ﹤0.01%
11,817
– –
NOAH
3848
Noah Holdings
NOAH
$603M
$261K ﹤0.01%
22,824
+1,243
+6% +$14.4K
OPXS icon
3849
Optex Systems
OPXS
$83.4M
$261K ﹤0.01%
34,124
+8,369
+32% +$53.3K
SMSI icon
3850
Smith Micro Software
SMSI
$16.2M
$261K ﹤0.01%
18,914
+432
+2% +$10.9K
152 153
154
155 156

Similar funds

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.

  • Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
  • Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
  • Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
  • Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
  • Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
  • Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.